ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,565 | -22.6% | 7,762 | +2.8% | 0.00% | -100.0% |
| Q2 2023 | $269,304 | +22.8% | 7,552 | -12.6% | 0.00% | 0.0% |
| Q1 2023 | $219,380 | -34.0% | 8,637 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $332,611 | +42.8% | 8,637 | +22.5% | 0.00% | 0.0% |
| Q3 2022 | $233,000 | -6.8% | 7,053 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $250,000 | +25.6% | 7,088 | +64.1% | 0.00% | 0.0% |
| Q1 2022 | $199,000 | -29.9% | 4,319 | +6.2% | 0.00% | 0.0% |
| Q4 2021 | $284,000 | +5.2% | 4,065 | -6.1% | 0.00% | 0.0% |
| Q3 2021 | $270,000 | -24.6% | 4,328 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $358,000 | +0.3% | 4,328 | -19.7% | 0.00% | 0.0% |
| Q1 2021 | $357,000 | +31.7% | 5,388 | +52.5% | 0.00% | 0.0% |
| Q4 2020 | $271,000 | +19.4% | 3,532 | -33.1% | 0.00% | 0.0% |
| Q3 2020 | $227,000 | +0.9% | 5,283 | +1.5% | 0.00% | -33.3% |
| Q2 2020 | $225,000 | – | 5,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |